ConductScience.org, home

Paper7650671

Vinyl sulfones as mechanism-based cysteine protease inhibitors.

Palmer JT and 3 others. J Med Chem, 1995. Cited by 400 papers, by iCite.

Cite this record

ConductScience Library. Vinyl sulfones as mechanism-based cysteine protease inhibitors. Papers, record 7650671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7650671

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vinyl sulfones as mechanism-based cysteine protease inhibitors.
PubMed
Journal
J Med Chem
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
400
iCite
Relative citation ratio, by iCite
9.89
iCite
Revised in PubMed
2019-07-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Palmer JTJ T
2Rasnick DD
3Klaus JLJ L
4Brömme DD

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cysteine Proteinase InhibitorsMajor topic
SulfonesMajor topic
Amino Acid Sequence
Drug Design
Kinetics
Molecular Sequence Data

Cited by121

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 400 citations.

PMIDTitleJournalYearIn PapersSource
42704525Development and preclinical evaluation of selective vinyl sulfone-based probes for PET imaging of tumor-associated cathepsins.EJNMMI Radiopharm Chem2026https://conductscience.org/library/papers/42704525PubMed
42381118Engineering Cathepsin S Selective Chemical Probes and Antibody-Drug Conjugates through Substrate Profiling with Unnatural Amino Acids.J Med Chem2026https://conductscience.org/library/papers/42381118PubMed
41155577A Second Opportunity for the Peptide-Based Analogues with γ-Lactam at the P1 Position: Human Cathepsin S Inhibition.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155577PubMed
41022736Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregation.NPJ Parkinsons Dis2025https://conductscience.org/library/papers/41022736PubMed
40739688Organosulfur Compounds: Potential Therapeutics for Parkinson's Disease.CNS Neurol Disord Drug Targets2026https://conductscience.org/library/papers/40739688PubMed
40278767Combating Malaria: Targeting the Ubiquitin-Proteasome System to Conquer Drug Resistance.Trop Med Infect Dis2025https://conductscience.org/library/papers/40278767PubMed
40151260Development and Application of Small Molecule-Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer.JACS Au2025https://conductscience.org/library/papers/40151260PubMed
39311309Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development.Pathophysiology2024https://conductscience.org/library/papers/39311309PubMed
39236162Palladium-catalyzed cross-coupling of alcohols with olefins by positional tuning of a counteranion.Science2024https://conductscience.org/library/papers/39236162PubMed
39157084Clickable Probes for Pathogen Proteasomes: Synthesis and Applications.ACS Omega2024https://conductscience.org/library/papers/39157084PubMed
38384945Flavin-Mediated Photocatalysis Provides a General Platform for Sulfide C-H Functionalization.ACS Catal2024https://conductscience.org/library/papers/38384945PubMed
37921174Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs.Curr Med Chem2024https://conductscience.org/library/papers/37921174PubMed
37857662Mechanistic insights into excited-state palladium catalysis for C-S bond formations and dehydrogenative sulfonylation of amines.Nat Commun2023https://conductscience.org/library/papers/37857662PubMed
37498810Advances in new target molecules against schistosomiasis: A comprehensive discussion of physiological structure and nutrient intake.PLoS Pathog2023https://conductscience.org/library/papers/37498810PubMed
37443395Molecular basis for ubiquitin/Fubi cross-reactivity in USP16 and USP36.Nat Chem Biol2023https://conductscience.org/library/papers/37443395PubMed
36867428Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins.J Med Chem2023https://conductscience.org/library/papers/36867428PubMed
35955599An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects.Int J Mol Sci2022https://conductscience.org/library/papers/35955599PubMed
35883746The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects.Antioxidants (Basel)2022https://conductscience.org/library/papers/35883746PubMed
35852812Two Tags in One Probe: Combining Fluorescence- and Biotin-based Detection of the Trypanosomal Cysteine Protease Rhodesain.Chemistry2022https://conductscience.org/library/papers/35852812PubMed
35002435Exploring the role of cathepsin in rheumatoid arthritis.Saudi J Biol Sci2022https://conductscience.org/library/papers/35002435PubMed

See all 121 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7650671

GET https://conductscience.org/api/papers/v1/7650671/cited_by?page=2